📦 NDC / package directory — not a drug information page
Epoprostenol NDCs, Package Codes, Strengths & Labelers
This page lists NDC package records for Epoprostenol products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.
Looking for uses, warnings & side effects? Read our Epoprostenol drug information page →Key stats
9
Package NDCs
9
Products
9
Active listings
0
Discontinued
5
Labelers
4
Strengths
1
Dosage forms
0
With NADAC pricing
By strength, form & labeler
NDC products by strength
By dosage form
Top labelers
Browse records — 9 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Epoprostenol 1.5 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 68083-0642-01 | — | On market | View → |
| Epoprostenol .5 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 68083-0707-01 | — | On market | View → |
| epoprostenol 1.5 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 62756-0060-40 | — | On market | View → |
| Epoprostenol 1.5 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 62287-0123-01 | — | On market | View → |
| EPOPROSTENOL 1.5 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 67457-0588-10 | — | On market | View → |
| EPOPROSTENOL .5 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 67457-0587-10 | — | On market | View → |
| epoprostenol .5 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 62756-0059-40 | — | On market | View → |
| Veletri epoprostenol 1.5 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 66215-0402-01 | — | On market | View → |
| Veletri epoprostenol .5 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 66215-0403-01 | — | On market | View → |
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.